मुख्यपृष्ठ › प्रोस्टेट कर्करोग › इलिनॉय › Chicago
Chicago, IL मधील प्रोस्टेट कर्करोग साठी क्लिनिकल ट्रायल्स
Chicago आणि आजूबाजूच्या ठिकाणी (सुमारे 30 मैलांच्या आत) प्रोस्टेट कर्करोग साठी 45 अभ्यास सहभागी शोधत आहेत. कोण सहभागी होऊ शकते आणि अभ्यास संघाशी संपर्क कसा साधावा हे पाहण्यासाठी अभ्यास उघडा.
अधिकृत अभ्यास मजकूर (इंग्रजी)
अभ्यासासाठी सहभागी शोधत आहात? हे पृष्ठ शीर्षस्थानी दर्शवा — 30 दिवसांसाठी $99 →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
निवड सुरू आहेफेज 3
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
निवड सुरू आहेफेज 1
- University of Chicago Hospital, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
निवड सुरू आहेनिरीक्षण अभ्यासस्वस्थ स्वयंसेवकांचे स्वागत आहे
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- आणि आणखी 1
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
निवड सुरू आहेफेज 2
- University of Illinois Cancer Center, Chicago
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
निवड सुरू आहेफेज 2
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
निवड सुरू आहेफेज 2/3
- University of Chicago, Chicago
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
निवड सुरू आहेफेज 3
- University of Illinois Chicago, Chicago
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
- University of Illinois Cancer Center at Chicago, Chicago
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
निवड सुरू आहेफेज 3
- Research Site, Chicago
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
निवड सुरू आहेफेज 3
- Rush University Medical Center-Hematology and Oncology ( Site 0028), Chicago
- University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0063), Chicago
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
- University of Illinois, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
निवड सुरू आहेफेज 1
- University of Illinois Hospital & Health Sciences System, Chicago
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
निवड सुरू आहे
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
निवड सुरू आहेफेज 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
निवड सुरू आहेफेज 2
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
निवड सुरू आहेफेज 1/2
- University of Chicago, Chicago
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
निवड सुरू आहेफेज 1
- University of Chicago Medical Center, Chicago
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
निवड सुरू आहेफेज 1/2
- Research Site, Chicago
PSMA PET Combined With MRI for the Detection of PCa
निवड सुरू आहेफेज 3स्वस्थ स्वयंसेवकांचे स्वागत आहे
- UroPartners,LLC, Chicago
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
निवड सुरू आहेफेज 3
- Rush MD Anderson, Chicago
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
निवड सुरू आहेफेज 3
- University of Illinois, Chicago
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
निवड सुरू आहेफेज 2
- Northwestern University, Chicago
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
निवड सुरू आहेलवकर फेज 1स्वस्थ स्वयंसेवकांचे स्वागत आहे
- Northwestern University, Chicago
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
निवड सुरू आहेफेज 2
- UChicago Medicine Comprehensive Cancer Center, Chicago
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
निवड सुरू आहेनिरीक्षण अभ्यास
- University of Illinois at Chicago, Chicago
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago, Chicago
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
निवड सुरू आहेनिरीक्षण अभ्यासस्वस्थ स्वयंसेवकांचे स्वागत आहे
- Northwestern, Chicago
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
निवड सुरू आहेफेज 1
- Research Site, Chicago
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
निवड सुरू आहेफेज 1/2
- Rush University, Chicago
Clinical Trial of Approaches to Prostate Cancer Surgery
निवड सुरू आहे
- Northwestern University, Chicago
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
निवड सुरू आहेफेज 2
- Northwestern University, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
निवड सुरू आहेफेज 1/2
- University of Chicago Medical Center, Chicago
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
निवड सुरू आहे
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
GU-01: Glycyrrhizin in Prostate Cancer
निवड सुरू आहेफेज 2
- University of Illinois, Chicago
PSMA PET for Surveillance After Focal Therapy
निवड सुरू आहे
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
निवड सुरू आहेफेज 1
- The University of Chicago Comprehensive Cancer Center, Chicago
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
निवड सुरू आहेनिरीक्षण अभ्यास
- The University of Chicago, Hyde Park · 5 मैल दूर
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
- University of Illinois, Chicago
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
निवड सुरू आहेफेज 4
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
निवड सुरू आहेनिरीक्षण अभ्यास
- Massive Bio SYNERGY-AI site, Chicago
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
निवड सुरू आहे
- The University of Illinois at Chicago (UIC), Chicago
- UChicago Medicine Comprehensive Cancer Center, Chicago
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
निवड सुरू आहेफेज 3
- Rush University Medical Center, Chicago
- University of Illinois, Chicago
Geriatric Assessment and Technology Evaluation in Prostate Cancer
निवड सुरू आहेनिरीक्षण अभ्यास
- o University of Chicago Medicine Comprehensive Cancer Center, Chicago
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
निवड सुरू आहेफेज 4
- University of Chicago Medical Center, Chicago
इतर शहरांतील प्रोस्टेट कर्करोग ट्रायल्स
- New York City, NY103 अभ्यास
- Houston, TX76 अभ्यास
- Los Angeles, CA61 अभ्यास
- Boston, MA59 अभ्यास
- St. Louis, MO46 अभ्यास
- San Francisco, CA45 अभ्यास
- Philadelphia, PA44 अभ्यास
- Baltimore, MD43 अभ्यास
- Nashville, TN42 अभ्यास
- Seattle, WA42 अभ्यास
- Washington, DC38 अभ्यास
- Dallas, TX36 अभ्यास
Chicago मधील इतर अभ्यास
- नॉन-स्मॉल सेल लंग कॅन्सर61 अभ्यास
- स्तनाचा कर्करोग58 अभ्यास
- कर्करोग (सर्व प्रकार)51 अभ्यास
- मेटास्टॅटिक कर्करोग45 अभ्यास
- स्थूलता41 अभ्यास
- फुफ्फुसाचा कॅन्सर41 अभ्यास
- अंडाशयाचा कर्करोग36 अभ्यास
- स्ट्रोक34 अभ्यास
- कोलोरॅक्टल कॅन्सर33 अभ्यास
- हृदयाची अशक्तपणा31 अभ्यास
- अतिवजन28 अभ्यास
- डोके आणि मानेचा स्क्वॅमस सेल कार्सिनोमा26 अभ्यास
ClinicalTrials.gov वरून, 5 ऑक्टो, 2026 रोजी मिळालेली माहिती. प्रत्येक अभ्यासासाठी पात्रतेचे निकष वेगळे असतात; अभ्यास संघ ठरवतो की कोण सहभागी होऊ शकते.